RODRIGO SANTILLAN: Open Payments
NPI 1477024602 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 51 payments from 22 companies in 2025. Trend: 2023 $331 · 2024 $1,000 · 2025 $1,095
Food & beverage: $1,095
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $230 |
| Phathom Pharmaceuticals, Inc. | 4 | $156 |
| Lilly USA, LLC | 8 | $119 |
| Novo Nordisk Inc | 5 | $106 |
| Amgen Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Abbott Laboratories | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
Products named: VOQUEZNA, AIRSUPRA, FARXIGA, Ozempic, JARDIANCE, MOUNJARO, AJOVY, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
